These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30030660)

  • 1. Invasive non-urachal adenocarcinoma of the bladder: analysis of the National Cancer Database.
    Davaro F; Schaefer J; May A; Raza J; Siddiqui S; Hamilton Z
    World J Urol; 2019 Mar; 37(3):497-505. PubMed ID: 30030660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database.
    Fischer-Valuck BW; Rao YJ; Rudra S; Przybysz D; Germino E; Samson P; Baumann BC; Gay H; Michalski J
    J Urol; 2018 Feb; 199(2):416-423. PubMed ID: 28842247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
    Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
    JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
    Efstathiou JA; Spiegel DY; Shipley WU; Heney NM; Kaufman DS; Niemierko A; Coen JJ; Skowronski RY; Paly JJ; McGovern FJ; Zietman AL
    Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
    Giacalone NJ; Shipley WU; Clayman RH; Niemierko A; Drumm M; Heney NM; Michaelson MD; Lee RJ; Saylor PJ; Wszolek MF; Feldman AS; Dahl DM; Zietman AL; Efstathiou JA
    Eur Urol; 2017 Jun; 71(6):952-960. PubMed ID: 28081860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
    Fischer-Valuck BW; Rao YJ; Henke LE; Rudra S; Hui C; Baumann BC; Gay HA; Michalski JM
    Eur Urol Focus; 2018 Dec; 4(6):900-906. PubMed ID: 28919521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary adenocarcinoma of the urinary bladder: a single site analysis of 21 cases.
    Zhang H; Jiang H; Wu Z; Fang Z; Fan J; Ding Q
    Int Urol Nephrol; 2013 Feb; 45(1):107-11. PubMed ID: 23054322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant urachal neoplasms: A population-based study and systematic review of literature.
    Mylonas KS; O Malley P; Ziogas IA; El-Kabab L; Nasioudis D
    Urol Oncol; 2017 Jan; 35(1):33.e11-33.e19. PubMed ID: 27592530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.
    Gray PJ; Fedewa SA; Shipley WU; Efstathiou JA; Lin CC; Zietman AL; Virgo KS
    Eur Urol; 2013 May; 63(5):823-9. PubMed ID: 23200811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation.
    Zhong J; Switchenko J; Jegadeesh NK; Cassidy RJ; Gillespie TW; Master V; Nieh P; Alemozaffar M; Kucuk O; Carthon B; Filson CP; Bilen MA; Jani AB
    Am J Clin Oncol; 2019 Jan; 42(1):36-41. PubMed ID: 29912804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
    J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging.
    Lin HY; Ye H; Kernen KM; Hafron JM; Krauss DJ
    Cancer Med; 2018 Nov; 7(11):5370-5381. PubMed ID: 30306728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary adenocarcinoma of urinary bladder.
    Nocks BN; Heney NM; Daly JJ
    Urology; 1983 Jan; 21(1):26-9. PubMed ID: 6823700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of Korean patients with clinically localized urachal or non-urachal adenocarcinoma of the bladder.
    Cho SY; Moon KC; Park JH; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2013 Jan; 31(1):24-31. PubMed ID: 21458312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.
    Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD
    Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charlson comorbidity score is associated with readmission to the index operative hospital after radical cystectomy and correlates with 90-day mortality risk.
    McFerrin C; Raza SJ; May A; Davaro F; Siddiqui S; Hamilton Z
    Int Urol Nephrol; 2019 Oct; 51(10):1755-1762. PubMed ID: 31346955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder preservation for localized muscle-invasive bladder cancer: the survival impact of local utilization rates of definitive radiotherapy.
    Kozak KR; Hamidi M; Manning M; Moody JS
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e197-204. PubMed ID: 22401916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional small cell carcinoma of the bladder: clinical characteristics and treatment patterns.
    Patel SG; Stimson CJ; Zaid HB; Resnick MJ; Cookson MS; Barocas DA; Chang SS
    J Urol; 2014 Feb; 191(2):329-34. PubMed ID: 24036236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis.
    Shimizu F; Muto S; Taguri M; Ieda T; Tsujimura A; Sakamoto Y; Fujita K; Okegawa T; Yamaguchi R; Horie S
    Int J Urol; 2017 May; 24(5):367-372. PubMed ID: 28281310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma of bladder.
    Dandekar NP; Dalal AV; Tongaonkar HB; Kamat MR
    Eur J Surg Oncol; 1997 Apr; 23(2):157-60. PubMed ID: 9158192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.